Interobserver variation of the histopathological diagnosis in clinical trials on glioma: a clinician’s perspective
Open accessThe DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Abstract
Several studies have provided ample evidence of a clinically significant interobserver variation of the histological diagnosis of glioma. This interobserver variation has an effect on both the typing and grading of glial tumors. Since treatment decisions are based on histological diagnosis and grading, this affects patient care: erroneous classification and grading may result in both over- and undertreatment. In particular, the radiotherapy dosage and the use of chemotherapy are affected by tumor grade and lineage. It also affects the conduct and interpretation of clinical trials on glioma, in particular of studies into grade II and grade III gliomas. Although trials with central pathology review prior to inclusion will result in a more homogeneous patient population, the interpretation and external validity of such trials are still affected by this, and the question whether results of such trials can be generalized to patients diagnosed and treated elsewhere remains to be answered. Although molecular classification may help in typing and grading tumors, as of today this is still in its infancy and unlikely to completely replace histological classification. Routine pathology review in everyday clinical practice should be considered. More objective histological criteria for the grade and lineage of gliomas are urgently needed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Histologic diagnosis and grading of gliomas have been limited by considerable intra- and interobserver variability (42).”
From Predicting cancer outcomes from histology and genomics using convolutional networks (2018) · cites this paper as [42]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“However, the grading criteria in the current classification schema for oligodendrogliomas continues to predominantly rely upon histopathologic examination; the differentiating criterion between grade 2 and grade 3 oligodendrogliomas are the presence of conspicuous microvascular proliferation and/or 6 mitoses per 10 high-power field [3,4,5,6,7,8,9,10,11].”
From BPC 157 Therapy of Myotendinous Junction Injury in Rats (2025) · cites this paper as [9]
Experimental — accuracy not yet measuredIn the citing paper
“Importantly, these data further facilitate consensus ratings on radiology images (e.g., MRI) of expert radiologists to alleviate inconsistencies that often arise due to subjective impressions and inter- and intra-observer variability [229].”
From AI in Medical Imaging Informatics: Current Challenges and Future Directions (2020) · cites this paper as [229]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The 2007 WHO Classification of Tumours of the Central Nervous System
Louis, D. N., Ohgaki, H., Wiestler, O. D., Cavenee, W. K., Burger, P. C., Jouvet, A., Scheithauer, B. W., & Kleihues, P. (2007) · Acta Neuropathologica · doi:10.1007/s00401-007-0243-4 · Cited by 15,397
External validity of randomised controlled trials: “To whom do the results of this trial apply?”
Rothwell, P. M. (2005) · The Lancet · doi:10.1016/s0140-6736(04)17670-8 · Cited by 2,544 · cited 1×
“This issue is on the question of external validation or generalizability of the results of a trial, an often ignored element of clinical trials [26].”
BackgroundCairncross, J. G., Ueki, K., Zlatescu, M. C., Lisle, D. K., Finkelstein, D. M., Hammond, R. R., Silver, J. S., Stark, P. C., Macdonald, D. R., Ino, Y., et al. (1998) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/90.19.1473 · Cited by 1,610
Feinstein, A. R., Sosin, D. M., & Wells, C. K. (1985) · New England Journal of Medicine · doi:10.1056/nejm198506203122504 · Cited by 1,544
An analysis of 8305 cases of carcinoid tumors
Modlin, I. M., & Sandor, A. (2000) · Cancer · doi:10.1002/(sici)1097-0142(19970215)79:4<813::aid-cncr19>3.0.co;2-2 · Cited by 1,200
Nutt, C. L., Mani, D. R., Betensky, R. A., Tamayo, P., Cairncross, J. G., Ladd, C., Pohl, U., Hartmann, C. J., McLaughlin, M. E., Batchelor, T. T., et al. (2003) · PubMed · Cited by 1,058
van den Bent, M., Afra, D., de Witte, O., Hassel, M. B., Schraub, S., Hoang-Xuan, K., Malmström, P.-O., Collette, L., Piérart, M., Mirimanoff, R., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67070-5 · Cited by 1,035
Wick, W., Hartmann, C., Engel, C., Stoffels, M., Felsberg, J., Stockhammer, F., Sabel, M. C., Koeppen, S., Ketter, R., Meyermann, R., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2009.23.6497 · Cited by 809
Smith, J. S., Perry, A., Borell, T. J., Lee, H. K., O’Fallon, J., Hosek, S. M., Kimmel, D., Yates, A., Burger, P. C., Scheithauer, B. W., et al. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.3.636 · Cited by 804
van den Bent, M. J., Carpentier, A. F., Brandes, A. A., Sanson, M., Taphoorn, M. J. B., Bernsen, H. J. J. A., Frenay, M., Tijssen, C. C., Grisold, W., Sipos, L., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.6078 · Cited by 748
Research works printed but not linked: 1
- Coons SW, Johnson PC, Scheithauer BW, Yates AJ, Pearl DK (1997) Improving diagnostic accuracy and interobserver concordance in the classification and grading of primary gliomas. Cancer 79:1381–1391 · doi:10.1002/(sici)1097-0142(19970401)79:7<1381::aid-cncr16>3.0.co;2-w
Cited by
Items 401–500 of 640
Delfanti, R. L., Piccioni, D. E., Handwerker, J., Bahrami, N., Krishnan, A., Karunamuni, R. A., Hattangadi-Gluth, J. A., Seibert, T. M., Srikant, A., Jones, K. A., et al. (2017) · Journal of Neuro-Oncology · doi:10.1007/s11060-017-2620-8 · Cited by 5
Matek, D., Pevec, D., Boban-Blagaic, A., & Sikiric, P. (2025) · Biomedicines · doi:10.3390/biomedicines13010201 · Cited by 4
Blobner, J., Ruf, V., Weller, J., Teske, N., Forbrig, R., Thon, N., Albert, N. L., von Baumgarten, L., Schoenecker, S. A., Tonn, J., et al. (2025) · Journal of Neuro-Oncology · doi:10.1007/s11060-025-05173-z · Cited by 4
Drucker, K. L., Panda, A., Decker, P. A., Kosel, M., Kollmeyer, T. M., Burns, T. C., Maqbool, M. A., Shafqat, S., Šuvakov, M., Zadeh, G. M., et al. (2026) · Neuro-Oncology · doi:10.1093/neuonc/noag019 · Cited by 4
Assigning a new glioma grade label ground-truth for the BraTS dataset using radiologic criteria
Dequidt, P., Bourdon, P., Tremblais, B., Guillevin, C., Gianelli, B., Boutet, C., Cottier, J., Vallée, J.-N., Fernández-Maloigne, C., & Guillevin, R. (2020) · International Conference on Image Processing Theory, Tools and Applications (IPTA) · doi:10.1109/ipta50016.2020.9286707 · Cited by 4
Yang, G., Shan, D., Zhao, R., & Li, G. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.902298 · Cited by 4
methylClass: an R package to construct DNA methylation-based classification models
Liu, Y. (2023) · Briefings in Bioinformatics · doi:10.1093/bib/bbad485 · Cited by 4
Computational Fractal-Based Analysis of Brain Tumor Microvascular Networks
Ieva, A. D., & Al-Kadi, O. S. (2024) · Advances in neurobiology · doi:10.1007/978-3-031-47606-8_27 · Cited by 4
Molecular Neuropathology and the Ontogeny of Malignant Gliomas
Huttner, A. J. (2016) · Springer eBooks · doi:10.1007/978-3-319-49864-5_2 · Cited by 4
Kim, M., Jeong, J. Y., Park, J. Y., & Park, J. Y. (2022) · In Vivo · doi:10.21873/invivo.12844 · Cited by 4
Li, Y., Li, X., & Yu, Z. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1177120 · Cited by 4
The Impact of Molecular and Genetic Analysis on the Treatment of Patients with Atypical Meningiomas
Ravnik, J., & Rowbottom, H. (2024) · Diagnostics · doi:10.3390/diagnostics14161782 · Cited by 4
Computational Fractal-Based Analysis of Brain Tumor Microvascular Networks
Ieva, A. D., & Al-Kadi, O. S. (2016) · Springer series in computational neuroscience · doi:10.1007/978-1-4939-3995-4_24 · Cited by 4
Rodríguez-Florido, M. A., Feria-Romero, I. A., Nettel-Rueda, B., Guerrero‐Cantera, J., Orozco-Suárez, S. A., Chavez, J. A., Guinto, G., & Grijalva, I. (2020) · Gaceta Médica de México · doi:10.24875/gmm.m20000329 · Cited by 4
T2/T2-FLAIR mismatch sign as a predictive biomarker for anaplastic astrocytoma genetic profile
Belyaev, A. Y., Usachev, D. Y., Pronin, I., Игоревич, Б. А., Afandiev, R. M., & Galstyan, S. A. (2021) · Medical Visualization · doi:10.24835/1607-0763-959 · Cited by 4
Anvari, K., Bahadorkhan, G., Samini, F., Izadpanahi, P., Bayatmokhtari, N., & Javadinia, S. A. (2015) · Reports of Radiotherapy and Oncology · doi:10.5812/rro.10598 · Cited by 4
AI drives the assessment of lung cancer microenvironment composition
Gallo, E., Guardiani, D., Betti, M., Arteni, B. A. M., Martino, S. D., Baldinelli, S., Daralioti, T., Merenda, E., Ascione, A., Visca, P., et al. (2024) · Journal of Pathology Informatics · doi:10.1016/j.jpi.2024.100400 · Cited by 3
Wang, X., Wang, Z., Wang, W., Liu, Z., Ma, Z., Guo, Y., Su, D., Sun, Q., Pei, D., Duan, W., et al. (2024) · iScience · doi:10.1016/j.isci.2024.111605 · Cited by 3
Turpo-Peqqueña, A. G., Luna-Prado, S., Valencia-Arce, R. J., Del-Carpio-Carrazco, F. L., & Gómez, B. (2025) · Current Issues in Molecular Biology · doi:10.3390/cimb47010040 · Cited by 3
Mojica, C. V., Gutierrez, K. M. E., & Mason, W. P. (2025) · Future Oncology · doi:10.1080/14796694.2025.2511587 · Cited by 3
Enda, K., Oda, Y., Tanei, Z., Satoh, K., Motegi, H., Terasaka, S., Yamaguchi, S., Ogawa, T., Wang, L., Tsuda, M., et al. (2026) · Pathology International · doi:10.1111/pin.70098 · Cited by 3
Studies for Better Treatment of Patients with Glioma
Malmström, A. (2019) · Linköping University medical dissertations · doi:10.3384/diss.diva-161677 · Cited by 3
Wu, Y., Walker, E., & Yuan, Y. (2024) · Current Oncology · doi:10.3390/curroncol31060234 · Cited by 3
Perspectives of Personalized Chemotherapy of Gliomas Based on Molecular Tumor Profiling
Soffietti, R., Franchino, F., Magistrello, M., Pellerino, A., & Rudà, R. (2018) · Progress in neurological surgery · doi:10.1159/000467378 · Cited by 3
Rodríguez-Florido, M. A., Feria-Romero, I. A., Nettel-Rueda, B., Guerrero‐Cantera, J., Orozco-Suárez, S. A., Chavez, J. A., Guinto, G., & Grijalva, I. (2019) · Gaceta Médica de México · doi:10.24875/gmm.19004832 · Cited by 3
Zhang, H., Xu, L., Zhong, Z., Liu, Y., Long, Y., & Zhou, S. (2020) · Academic Radiology · doi:10.1016/j.acra.2020.02.017 · Cited by 3
Bai, H., Bai, S., Li, X., Zhang, Y., Li, Y., He, F., & Cheng, W. (2021) · BioMed Research International · doi:10.1155/2021/3271395 · Cited by 3
Rich, K., Tosefsky, K. N., Martin, K. C., Bashashati, A., & Yip, S. S. F. (2024) · Cancers · doi:10.3390/cancers16111976 · Cited by 3
Consultative Issues in Surgical Neuropathology
Lipp, E., Clark, A. C., & McLendon, R. E. (2015) · American Journal of Clinical Pathology · doi:10.1309/ajcpwep1hpx4edcs · Cited by 3
Input of molecular analysis in medical management of primary brain tumor patients
Idbaïh, A., Durán-Peña, A., Bonnet, C., & Ducray, F. (2015) · Revue Neurologique · doi:10.1016/j.neurol.2015.04.002 · Cited by 3
Vega, J. E. V., & Brat, D. J. (2017) · Springer eBooks · doi:10.1007/978-3-319-55466-2_4 · Cited by 3
Pathology of Primary Brain Tumors—Gliomas
Wong, D., & Yip, S. S. F. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-811783-5.00006-9 · Cited by 3
Brown, P. D., Chan, M. D., Shaw, E. G., & van den Bent, M. J. (2015) · Elsevier eBooks · doi:10.1016/b978-0-323-24098-7.00026-5 · Cited by 3
Gyure, K. A., & Flanagan, M. B. (2015) · Cambridge University Press eBooks · doi:10.1017/9781139137201.049 · Cited by 3
Tumors of the Central Nervous System
Vega, J. E. V., Ballester, L. Y., & Schniederjan, M. (2021) · Springer eBooks · doi:10.1007/978-3-030-73227-1_6 · Cited by 3
Basic premises: searching for new targets and strategies in diffuse gliomas
Sansone, G., Vivori, N., Vivori, C., Stefano, A. L. D., & Pïcca, A. (2022) · Clinical and Translational Imaging · doi:10.1007/s40336-022-00507-7 · Cited by 3
Les inhibiteurs de l'apoptose, une nouvelle cible thérapeutique dans les glioblastomes
Soubéran, A. (2017) · theses.fr (ABES) · doi:10.70675/1f0777cfz9271z4073z8adfz7ad1a2513bf1 · Cited by 3
Flies, C. M., Snijders, T. J., Leeuw, B. I. D., van Maren, E. A., Kersten, B. J. P., Verhoeff, J. J. C., Vos, F. D., Robe, P. A. J. T., Hendrikse, J., & Dankbaar, J. W. (2024) · American Journal of Neuroradiology · doi:10.3174/ajnr.a8336 · Cited by 2
Chen, Y., Lin, S., Wu, J., Yu, W.-H., Harn, H., Tsai, W., Liu, C.-A., Kuo, K.-L., Yeh, C., & Tsai, S. (2024) · Cancers · doi:10.3390/cancers16132449 · Cited by 2
Cho, N. S., Le, V. L., Teraishi, A., Liu, V., Sanvito, F., Telesca, D., Nakajo, M., Wang, C., Oshima, S., Eldred, B. S. C., et al. (2025) · Neuro-Oncology · doi:10.1093/neuonc/noaf171 · Cited by 2
Ren, R., Zhu, A., Li, Y., Liu, H., Huang, G., Gu, J., Ni, J., & Miao, Z. (2025) · Frontiers in Radiology · doi:10.3389/fradi.2025.1648145 · Cited by 2
Barci, E., Mair, M. J., Reis, J., Müller, K. J., Isakaj, J., Istrefi, E., von Polenz, I., Siegmund, S. C., Kaiser, L., Preusser, M., et al. (2026) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-026-07760-2 · Cited by 2
Xia, Y., Zhou, J., Wang, M., Hu, T., Zhai, W., Zhang, Y., & Yu, Z. (2026) · Computerized Medical Imaging and Graphics · doi:10.1016/j.compmedimag.2026.102744 · Cited by 2
TET CpG sequence-context-specific DNA demethylation shapes progression of IDH-mutant gliomas
Hoogstrate, Y., Ghisai, S. A., van Hijfte, L., Head, R., de Heer, I. J., Padovan, M., de Wit, M., Vallentgoed, W., Dipasquale, A., Wijnenga, M. M. J., et al. (2026) · Cell Reports Medicine · doi:10.1016/j.xcrm.2026.102682 · Cited by 2
A contemporary molecular view of diffuse gliomas with implications for diagnosis
Yang, X., Brat, D. J., Li, J., Wang, X., & Tong, L. (2020) · Glioma · doi:10.4103/glioma.glioma_11_20 · Cited by 2
Грецких, К. В., & Токарев, А. С. (2021) · Russian journal of neurosurgery · doi:10.17650/1683-3295-2021-23-1-124-134 · Cited by 2
Evaluation of an ultrasound-guided freeze-core biopsy system for canine and feline brain tumors
Adams, B. S., Marino, D. J., Loughin, C. A., Marino, L. J., Southard, T. L., LESSER, M. L., Akerman, M. B., & Roynard, P. (2024) · Frontiers in Veterinary Science · doi:10.3389/fvets.2024.1284097 · Cited by 2
Huang, J., Wang, Q., Li, Z., Huang, X., Wang, W. J., & Liu, J. (2025) · Discover Oncology · doi:10.1007/s12672-025-03297-2 · Cited by 2
Highlights from the Literature
Huse, J. T., Abounader, R., Purow, B. W., Hegi, M. E., Soffietti, R., & Aldape, K. (2016) · Neuro-Oncology · doi:10.1093/neuonc/now215 · Cited by 2
Strickland-Marmol, L. B., Brem, S. S., Rojiani, A. M., & Rojiani, M. V. (2017) · PubMed · Cited by 2
Molecular Epidemiology of Diffuse Low-Grade Glioma
Jacobs, D. I., Claus, E. B., & Wrensch, M. (2017) · Springer eBooks · doi:10.1007/978-3-319-55466-2_3 · Cited by 2
Koo, T., Lim, D. H., Seol, H. J., Park, C., Kim, I. H., Chang, J. H., Lee, J., Jung, S., Gwak, H., Cho, K. H., et al. (2018) · Journal of Neuro-Oncology · doi:10.1007/s11060-018-2839-z · Cited by 2
The role of biomarkers in the diagnosis and treatment of oligodendrogliomas
Donovan, L. E., & Lassman, A. B. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-813158-9.00009-8 · Cited by 2
Yan, F., Zhuang, J., Yu, Q., Dou, Z., Jiang, X., Tan, S., Han, Y., Wu, X., Zang, Y., Li, C., et al. (2021) · ACS Sensors · doi:10.1021/acssensors.1c01168 · Cited by 2
Anaplastic astrocytoma and anaplastic oligodendroglioma of the brain: current state of the problem
Belyaev, A. Y., Usachev, D. Y., Pronin, I., Shults, E. I., & Игоревич, Б. А. (2021) · Burdenko s Journal of Neurosurgery · doi:10.17116/neiro20218504196 · Cited by 2
Proceedings of the 2021 National Toxicology Program Satellite Symposium
Elmore, S. A., Choudhary, S., Krane, G. A., Plumlee, Q., Quist, E. M., Suttie, A. W., Tokarz, D. A., Ward, J. M., & Cora, M. C. (2021) · Toxicologic Pathology · doi:10.1177/01926233211043497 · Cited by 2
Lo, W. B., & Rutka, J. T. (2019) · Springer eBooks · doi:10.1007/978-3-030-04152-6_22 · Cited by 2
Gliomas of the Optic Nerve: A SEER-Based Epidemiologic Study
Dihowm, F., Alvarado, L. A., & Margo, C. E. (2022) · Journal of Neuro-Ophthalmology · doi:10.1097/wno.0000000000001630 · Cited by 2
Yuan, F., Wang, Y., Cai, X., Du, C., Zhu, J., Tang, C., Yang, J., & Ma, C. (2022) · Exploration of Targeted Anti-tumor Therapy · doi:10.37349/etat.2022.00100 · Cited by 2
A pathologist's guide for the diagnostic workup of paediatric central nervous system tumours
D’Arcy, C. E., & Hawkins, C. E. (2024) · Pathology · doi:10.1016/j.pathol.2024.10.002 · Cited by 2
WHO Guidelines for Diagnosis of Glial Tumours: What Is Old and What Is New?
Kros, J. M. (2011) · Journal für Kardiologie (Krause & Pachernegg GmbH) · Cited by 2
The Identification and Validation of Novel Aptamers to Glioma
Norris, K. (2014) · CLOK (University of Central Lancashire) · Cited by 2
Extent of resection for low-grade gliomas – Prognostic or therapeutic?
Kinslow, C. J., Garton, A. L. A., Rae, A. I., Kocakavuk, E., McKhann, G. M., Cheng, S. K., Sisti, M. B., Bruce, J. N., & Wang, T. J. C. (2024) · Clinical Neurology and Neurosurgery · doi:10.1016/j.clineuro.2024.108117 · Cited by 2
Spatial Analysis for AI-segmented Histopathology Images: Methods and ImplementationPreprint
Park, Y., Wu, F., Feng, X., Yang, S., Wang, E. H., Yao, B., Moon, C., Xiao, G., & Li, Q. (2025) · arXiv (Cornell University) · doi:10.48550/arxiv.2512.06116 · Cited by 2
Diffuse Gliomas (WHO Grade 2–3)
Ahmad, H., & Schiff, D. (2023) · doi:10.1093/med/9780197573778.003.0004 · Cited by 1
Future Directions in the Treatment of Low-Grade Gliomas
Kinslow, C. J., & Mehta, M. P. (2025) · The Cancer Journal · doi:10.1097/ppo.0000000000000759 · Cited by 1
INTER-OBSERVER VARIABILITY IN HISTOPATHOLOGICAL INTERPRETATION OF GLIOMAS
Nasir, S. (2025) · doi:10.53555/bgnecp46 · Cited by 1
Machine learning-based prediction of glioma grading
Liu, S., Xie, Y., Gong, X., He, J., & Zou, W. (2025) · PLoS ONE · doi:10.1371/journal.pone.0314831 · Cited by 1
Su, Y., Sun, J., Fu, R., Li, X., Bai, J., Li, F., Yang, H., Cheng, Y., & Lu, J. (2026) · Diagnostics · doi:10.3390/diagnostics16030458 · Cited by 1
Performance Benchmarking of YOLO Models for Colorectal Cancer Histopathology Image Classification
Khokhariya, A., Sarda, J. S., Pradhan, V., Vaghela, R., Dave, M. C., & Thakkar, A. R. (2025) · International Conference on Modeling, Simulation & Intelligent Computing (MoSICom) · doi:10.1109/mosicom67153.2025.11398311 · Cited by 1
Cho, M., Kim, M., Kim, H., Choi, K., Han, K., Ahn, S. S., Yoon, H. I., Chang, J. H., Kim, S. H., Lee, S.-K., et al. (2026) · Neuro-Oncology · doi:10.1093/neuonc/noag096 · Cited by 1
Gui, K., Li, Q., Xie, Z. Y., Zhan, T., Long, X., Yang, G., Luo, K., & Liu, H. (2026) · Progress in Biomedical Engineering · doi:10.1088/2516-1091/ae7860 · Cited by 1
An Expanded T2 ‐ FLAIR Mismatch Phenotype in IDH ‐Mutant Astrocytomas
Hua, T., Zhang, X., Li, J., Jin, Y., Qiu, J., Liu, Y., Cheng, D., Duan, Y., Liu, X., Zhuo, Z., et al. (2026) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.70404 · Cited by 1
Guarnaccia, M., & Cavallaro, S. (2026) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.70503 · Cited by 1
Ducray, F. (2011) · Pratique Neurologique - FMC · doi:10.1016/j.praneu.2011.02.010 · Cited by 1
Bush, N. A. O., Yang, D. Z., Clarke, J. L., & Haas-Kogan, D. A. (2017) · Wiley eBooks · doi:10.1002/9781119196235.ch62 · Cited by 1
Vonhoff, C. R., Lochhead, A., Koustais, S., Watson, N., Andrici, J., Brewer, J. M., & Gill, A. J. (2015) · Medicine · doi:10.1097/md.0000000000002131 · Cited by 1
Pessina, F., Navarria, P., Cozzi, L., Tomatis, S., Clerici, E., Ascolese, A. M., Simonelli, M., Perrino, M., Riva, M., Rossi, M., et al. (2017) · CNS Oncology · doi:10.2217/cns-2016-0043 · Cited by 1
Correlation of Frozen Section and Routine Histopathological Findings in Brain Tumors
(2017) · International Journal of Current Research and Review · doi:10.7324/ijcrr.2017.9208 · Cited by 1
How does one do next-generation sequencing for brain tumors in the clinical laboratories?
Li, K.-W., & Ng, H. (2018) · Glioma · doi:10.4103/glioma.glioma_36_18 · Cited by 1
Diffuse low grade gliomas - how it is to diagnose and treat effectively?
Reguli, Š., Cvek, J., & Lipina, R. (2019) · Onkologie · doi:10.36290/xon.2019.025 · Cited by 1
Pathology and Classification of Tumors of the Central Nervous System
Reifenberger, G., Blümcke, I., Wesseling, P., Pietsch, T., & Paulus, W. (2019) · Springer eBooks · doi:10.1007/978-3-030-04152-6_1 · Cited by 1
Bobach, I. S., & Stougaard, M. (2021) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2021.104621 · Cited by 1
Olive, K. M., Marie, K. M. J., & Manini, C. (2021) · International Journal of Immunology · doi:10.11648/j.iji.20210902.12 · Cited by 1
Comparative Diagnostics and Immunopathology of Canine Glioma.
Krane, G. A. (2021) · NCSU Libraries Repository (North Carolina State University Libraries) · Cited by 1
Bioinformatics in Mental Health: Deriving Knowledge from Molecular and Cellular Data
Bhuvaneshwar, K., & Gusev, Y. (2021) · Health informatics · doi:10.1007/978-3-030-70558-9_11 · Cited by 1
Highlights from the Literature
Lawler, S. E., Schiff, D., Hegi, M. E., Soffietti, R., & Aldape, K. (2015) · Neuro-Oncology · doi:10.1093/neuonc/nov080 · Cited by 1
Maimaiti, A., Liu, Y., Abulaiti, A., Wang, X., Feng, Z., Wang, J., Mijiti, M., Turhon, M., Alimu, N., Wang, Y., et al. (2023) · Journal of Molecular Neuroscience · doi:10.1007/s12031-023-02116-z · Cited by 1
Su, C., Peng, C., Sun, Y., Damen, F. C., Jiang, R., Xie, C., & Cai, K. (2023) · Turkish Neurosurgery · doi:10.5137/1019-5149.jtn.42484-22.3 · Cited by 1
Role of molecular markers in diagnosis and prognosis of gliomas
Pandey, A. K., & Verma, S. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-18508-3.00013-9 · Cited by 1
Pandey, A. K., & Verma, S. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-18508-3.00005-x · Cited by 1
Estudio de biomarcadores en gliomas y su utilidad clínica
Martínez, A. G. (2016) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) · Cited by 1
Clinical implications of PIK3CA mutations in gliomas molecular subgroups
Brito, C. (2018) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) · Cited by 1
Kinker, G. S. (2020) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.41.2020.tde-13022020-101209 · Cited by 1
ROR1 is a novel putative druggable target for diffuse gliomaPreprint
John, M., Rao, P., Noor, H., & Ford, C. E. (2021) · medRxiv · doi:10.1101/2021.12.03.21267166 · Cited by 1
Ninatti, G., Moresco, R. M., & Sollini, M. (2024) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-024-06591-3 · Cited by 1
Chegedekova, I., Kapsalyamov, A., Jamwal, P. K., Kystaubayeva, Z., Parthimos, D., & Jasani, B. (2025) · Preprints.org · doi:10.20944/preprints202508.0341.v1 · Cited by 1
A systems approach to the different grades and progression of human astrocytoma
Wang, C. (2011) · Illinois Digital Environment for Access to Learning and Scholarship (University of Illinois at Urbana-Champaign)
Dong-feng, C. (2013) · Lund University Publications (Lund University)
Brain tumor microarray data analyzed using clustering and novel consensus clustering techniques
Mesa, M., & Antonio, J. L. B. (2014) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
Metadata
- Authors
- van den Bent, M. J.
- Venue
- Acta Neuropathologica
- Published
- 2010-07-20
- Volume
- 120
- Issue
- 3
- Pages
- 297-304
- ISSN
- 0001-6322 (ISSN-L)
- 1432-0533
- PMC
- PMC2910894
- OpenAlex
- W2112567075
- Cited by
- 577
- References
- 35
- Citations by year
- 2026: 19 · 2025: 36 · 2024: 70 · 2023: 43 · 2022: 43 · 2021: 47 · 2020: 48 · 2019: 52 · 2018: 33 · 2017: 46 · 2016: 44 · 2015: 33 · 2014: 16 · 2013: 16 · 2012: 20
- FWCI
- 6.54
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc
- Locations
- Acta Neuropathologica (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- EUR Research Repository (Erasmus University Rotterdam) (publishedVersion)
- EUR Research Repository (Erasmus University Rotterdam) (submittedVersion)
- Topics
- Health Sciences › Medicine › Oncology › Glioma Diagnosis and Treatment
- Social Sciences › Decision Sciences › Statistics, Probability and Uncertainty › Reliability and Agreement in Measurement
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Radiomics and Machine Learning in Medical Imaging
- Keywords
- glioma, interobserver variability, histopathological diagnosis, tumor grading, tumor classification, central pathology review, clinical trial interpretation, generalizability, molecular classification, chemotherapy
- MeSH terms
- Brain Neoplasms, Clinical Trials as Topic, Glioma, Humans, Observer Variation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.